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INTRODUCTION
Hypocalcemia may present as an asymptomatic 
laboratory finding or as a severe, life-threatening condition. 
Upon the diagnosis of acute hypocalcemia, a rapid 
treatment regimen may be necessary. In contrast, chronic 
hypocalcemia may be well tolerated by the patient, but 
treatment nonetheless remains necessary in order to prevent 
long-term complications.
The hallmark of acute hypocalcemia is neuromuscular 
irritability, although paresthesias of the extremities may 
also occur, along with fatigue and anxiety. In addition, 
very painful muscle cramps may develop and can progress 
into carpal spasms or tetany.1 From a clinical perspective, 
neuromuscular irritability can be demonstrated by testing 
for Chevostek or Trousseau signs. However, all of these 
symptoms can be corrected by the administration of calcium 
replacement treatments. 
The observation of an inappropriately normal PTH 
coupled with hypocalcemia should promptly warrant the 
diagnosis of hypoparathyroidism, which may be transient, 
genetically inherited, or acquired due to an autoimmune 
process. It may also follow surgery or neck irradiation 
treatment.1
In this paper, we present a case study of a patient with 
primary hypoparathyroidism who is surprisingly resistant 
to the usual treatment consisting of calcium and vitamin 
D supplementation. The coincident observation of chronic 
diarrhea prompted us to consider the possibility of a 
malabsorption syndrome with steatorrhea, since vitamin D 
absorption is fat-dependent. 
CASE REPORT
A 39-year-old woman was admitted to the emergency 
room at our facility with tetany that was resolved by the 
intravenous administration of calcium gluconate in high 
doses. The patient’s recent medical history revealed recurrent 
episodes of diarrhea, asthenia, paresthesias and weight 
loss (7.0 kg) over a one-month period. Approximately one 
year prior to this emergency room admission, the patient 
underwent a quadrantectomy for breast cancer. Overall, the 
patient’s family history was unremarkable. At the time of 
admission, the patient was being treated with tamoxifen. 
Subsequent physical examination revealed a lean woman 
(body mass index of 22.7 kg/m2) with a blood pressure of 
120 over 60 mmHg and a heart rate of 100 beats per minute. 
In addition, the patient had a +/3 bilateral maleolar edema 
and no vitiligo was observed. The thyroid and the abdomen 
of the patient appeared normal. 
Initial laboratory analyses revealed that the patient was 
hypocalcemic (total calcium of 5.4 mg/dL and ionized 
calcium of 0.74 mM/L), hypoalbuminemic (2.4 g/dL) and 
presented microcytic hypochromic anemia (9.4 g/dL). The 
PTH (30 nM/L), phosphorus (4.4 mg/dL) and magnesium 
concentrations (2.1 mg/dL) were normal. A liver functional 
test revealed a high prothrombin time (25 seconds) with 
normal transaminases and bilirubin levels. In addition, renal 
and thyroid function tests were normal. 
The patient was placed on a high protein diet and treated 
with oral calcium gluconate and calcitriol with a stepwise 
increase in the dosage of up to 1.0 mg/day, with persistence 
of the paresthesia, Chevostek and Trousseau signs, and 
maleolar edema and without significant changes in metabolic 
and nutritional parameters (Figure 1). The patient’s serum 
analysis indicated the presence of immunoglobulin A 
isotype antibodies against endomysium (1/640). Diagnosis 
of gluten-sensitive enteropathy or celiac disease was 
suggested at endoscopy, due to flat mucosa, and confirmed 
by histological findings in duodenal biopsy, including absent 
villi, crypt hyperplasia and T-cell lymphocytic infiltration 
in the epithelium. Eleven days after admitting the patient, 
she was placed on a gluten-free diet, which rapidly lead 
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to the normalization of her bowel habits and improved her 
metabolic and nutritional parameters. 
The patient was discharged from the hospital after 7 
days on a gluten-free diet supplemented with daily doses of 
calcitriol (1.0 mg/day) and calcium carbonate (4.5 g/day). 
Her body mass index was 25.5 kg/m2 and blood pressure and 
heart rate were 120 over 80 mmHg and 80 bets per minute, 
respectively. Maleolar edema was no longer observed and the 
Chevostek and Trousseau signs were negative. In addition, 
the levels of total calcium, ionized calcium, albumin and 
hemoglobin increased to 8.3 mg/dL, 1.1 mM/L, 4.2 g/dL 
and 11.3 g/dL, respectively, while the prothrombin time 
decreased from 25 seconds to 11 seconds.
Six months thereafter, although the patient still reported 
occasional episodes of diarrhea, assays for the endomysial 
antibody were negative.
DISCUSSION
This patient had a history of chronic diarrhea and weight 
loss. Upon admission, laboratory analyses indicated that 
the patient had low levels of total calcium and ionized 
calcium that were initially observed under conditions of 
inappropriately normal levels of PTH and magnesium. We 
diagnosed the patient with primary hypoparathyroidism and 
she was treated with intravenous calcium gluconate and 
vitamin D3 (calciferol) supplements that were administered 
via a stepwise increase of up to 0.25 mg four times a day. 
This is considered the maximum daily recommended dose.
Because the hypocalcemia persisted in the patient, 
we considered changing the diagnosis to malabsorption 
syndrome due to the presence of chronic diarrhea, since 
vitamin D absorption is fat-dependent. Assays for the 
presence of the endomysial antibody were positive and a 
subsequent biopsy of duodenal mucosa revealed results that 
were consistent with gluten-sensitive enteropathy or celiac 
disease. We then administered the patient a gluten-free diet 
in combination with vitamin D supplementation. This was 
followed by an encouraging increase in the levels of serum 
calcium over a period of several days until the patient’s 
bowel habits normalized and the symptoms of hypocalcemia 
reappeared.
Celiac disease is an immune disorder triggered by an 
environmental agent (the gliadin component of gluten) in 
genetically predisposed individuals.3 Epidemiological studies 
using IgA antibodies to gliadin and endomysium had a 
positive predictive value of 100%, with a prevalence of 1:22 
in first degree relatives of patients with celiac disease and a 
prevalence of 1:133 in the not-at-risk groups.4 
Hypocalcemia in celiac disease may arise from the 
impaired absorption of vitamin D or the loss of calcium 
through the binding of intraluminal calcium to unabsorbed 
fatty acids. Both secondary hypoparathyroidism due 
to hypomagnesemia5 and compensatory secondary 
hyperparathyroidism have been described elsewhere.6 
On the other hand, only a few reports have been 
published on the coexistence of primary hypoparathyroidism 
and celiac disease.7-14 The age of the disease onset 
ranged from early childhood14 to old age.12 In some 
reports, such as one describing a 62-year-old woman, 
hypoparathyroidism was diagnosed 33 years prior to the 
diagnosis of celiac disease,12 while in other reports, such 
as a report characterizing a 60 year-old man,7 the diagnosis 
of hypoparathyroidism was made concomitantly with the 
diagnosis of celiac disease. In a separate report, a patient 
with idiopathic autoimmune hypoparathyroidism who 
developed autoimmune hyperthyroidism (Graves’ disease) 
was subsequently diagnosed with celiac disease.13 The 
malabsorption of l-thyroxine was the only indication of the 
presence of celiac disease. In fact, a common immunological 
basis that associated the idiopathic hypothyroidism with 
the celiac disease was hypothesized in this instance.9 In yet 
another report, celiac disease was diagnosed in a patient 
with hypoparathyroidism in the absence of gastrointestinal 
symptoms.11
In conclusion, the possibility of celiac disease should be 
considered in patients with hypoparathyroidism that seems 
unduly difficult to treat. This should be evaluated even in the 
absence of gastrointestinal symptoms.
Figure 1 - The effect of a gluten-free diet on the ionized calcium levels in a 
patient with primary hypoparathyroidism associated with celiac disease
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